Star Health Q1 FY27 Earnings Call: Underwriting Profit Jumps 7x, PAT Rises 25% as Retail Health Growth Remains Strong

What Happened ?

During the Star Health Q1 FY27 Earnings Call, management emphasized that the company’s recent performance reflects the success of a long-term strategy focused on disciplined underwriting, portfolio optimization, prudent pricing and technology-led claims management rather than pursuing rapid market share expansion.

The company also celebrated 20 years of operations, highlighting that it has served more than 2.8 crore lives and remains India’s largest retail health insurer with significant long-term growth opportunities driven by increasing health insurance penetration. 

key details

Strong Operating Performance:

• Gross Written Premium increased 19% YoY.
• Fresh Retail Health business grew 37% YoY.
• Underwriting Profit increased to ₹111 crore.
• PAT rose 25% YoY.
• Investment income increased 10% YoY.
• CISR improved to 97%.

Note:

• Management highlighted that this marks the fourth consecutive quarter of improving underwriting profitability. 

Retail Health Business Remains Strong:

• 94% of fresh retail customers were new-to-insurance, compared with 90% a year earlier.
• Retail market share stood at 29%.
• More than 90% of retail business came through proprietary channels.
• Agency network expanded by approximately 20,000 agents during the quarter.
• Total agency strength reached 8.5 lakh agents.
• Agent productivity improved 19% YoY.

Note:

• Management said the company continues prioritising customer quality and underwriting discipline over maximizing market share. 

Digital & Direct Distribution Continue to Scale:

• Digital D2C remained the fastest-growing profitable distribution channel.
• D2C fresh business increased 142% YoY.
• 74% of digital fresh business originated through Star Health’s own platform.
• 98% of D2C customers were first-time insurance buyers.
• 97% of all new applications were digitally sourced.

Note:

• Management views proprietary digital distribution as a structural competitive advantage that improves acquisition economics and customer quality. 

Claims & Customer Experience Improve:

• Retail claim settlement ratio improved to 91%.
• Renewal ratio increased to 102%.
• More than 9.5 lakh claims settled during the quarter.
• Over 80% of claims were settled through the cashless hospital network.
• Customer Net Promoter Score (NPS) improved by 12 points to 65.

Note:

• Home healthcare and telemedicine services helped manage seasonal infectious diseases while improving customer convenience. 

AI & Technology Investments:

• Generative AI is being integrated into claims processing.
• AI and ML models continue improving fraud detection and underwriting.
• Customer app reached approximately 16 million downloads.
• Monthly active users exceeded 1.5 million.
• The ATOM Pro distribution platform won the Economic Times BFSI FinNext Award 2026 for InsurTech Product Excellence.

Note:

• Management described its proprietary health insurance data accumulated over two decades as a major competitive advantage supporting underwriting and claims decisions. 

Management Outlook:

Management indicated:

• Insurance revenue growth is expected to gradually improve toward 15–16% over the coming quarters.
• Expense ratio could improve by 30–40 basis points annually through technology and productivity gains.
• Pricing actions will continue on an annual actuarial basis.
• The company expects seasonal increases in claims during Q2 due to dengue, malaria and other infectious diseases.
• The long-term objective remains delivering mid- to high-teen ROE through disciplined execution rather than aggressive premium growth.

Note:

• Management reiterated that sustainable profitability remains the primary objective. 

Key Investor Q&A Takeaways:

• Management expects insurance revenue growth to gradually converge with premium growth as long-term policy accounting normalises.
• Telemedicine and wellness initiatives continue contributing to lower loss ratios.
• Reinsurance costs are expected to decline as legacy quota-share treaties phase out.
• Approximately 40% of fresh retail business now comes from long-term policies.
• Senior citizen policies account for less than 5% of the portfolio.
• The company believes it is well positioned for potential regulatory reforms due to its strong proprietary distribution network.

Note:

• Management consistently emphasized disciplined underwriting, measured pricing actions and long-term value creation throughout the Q&A session. 

Risk Analysis

Summary:

• While Star Health continues to improve underwriting profitability, future performance remains influenced by seasonal claims, regulatory developments and the company’s ability to sustain underwriting discipline as the retail health insurance market expands.

Key Risks:

• Higher claims during dengue and infectious disease seasons.
• Regulatory changes affecting commissions and expense management.
• Increased competition in retail health insurance.
• Medical inflation impacting claim costs.
• Execution risk associated with rapid digital expansion.
• Slower growth after the GST-related demand boost normalises.

Worst Case:

• If medical inflation accelerates, seasonal claims remain elevated and competitive pricing intensifies, underwriting margins and profitability could come under pressure despite continued premium growth.

Risk Level: Medium

Company Statement

• The company completed 20 years as India’s largest retail health insurer.
• Underwriting profitability has improved for four consecutive quarters.
• Growth strategy remains focused on profitable retail health business.
• Proprietary distribution continues to strengthen customer acquisition quality.
• AI and digital investments remain central to underwriting, claims and customer service.
• Management remains committed to sustainable, long-term profitable growth rather than pursuing market share alone.